IGF2BP2 and cancer: Our investigation has revealed that cancer stem cell-derived exosomal LUCAT1 enhances the stemness phenotype and chemoresistance of bladder cancer cells by upregulating HMGA1 expression through its interaction with IGF2BP2, thereby contributing to the oncogenicity of bladder cancer.